{"count": 7, "results": [{"_id": "18612412", "pmid": 18612412, "pmcid": "PMC2440506", "title": "The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies", "journal": "PLoS One", "authors": ["Medina RJ", "O'Neill CL", "Devine AB", "Gardiner TA", "Stitt AW"], "date": "2008-07-09T00:00:00Z", "doi": "10.1371/journal.pone.0002584", "meta_date_publication": "2008 Jul 9", "meta_volume": "3", "meta_issue": "7", "meta_pages": "e2584", "score": 50077.08, "text_hl": "The Pleiotropic Effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ on Retinal Microvascular Endothelium Has Important Implications for @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@Ischaemic Retinopathies@@@", "citations": {"NLM": "Medina RJ, O'Neill CL, Devine AB, Gardiner TA, Stitt AW. The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies PLoS One. 2008 Jul 9;3(7):e2584. PMID: 18612412", "BibTeX": "@article{18612412, title={The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies}, author={Medina RJ and O'Neill CL and Devine AB and Gardiner TA and Stitt AW}, journal={PLoS One}, volume={3}, number={7}, pages={e2584}}"}}, {"_id": "11879715", "pmid": 11879715, "title": "Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia.", "journal": "Diabetes Res Clin Pract", "authors": ["Sen K", "Misra A", "Kumar A", "Pandey RM"], "date": "2002-04-01T00:00:00Z", "doi": "10.1016/s0168-8227(01)00341-2", "meta_date_publication": "2002 Apr", "meta_volume": "56", "meta_issue": "1", "meta_pages": "1-11", "score": 50072.105, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ retards progression of @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@.", "citations": {"NLM": "Sen K, Misra A, Kumar A, Pandey RM. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract. 2002 Apr;56(1):1-11. PMID: 11879715", "BibTeX": "@article{11879715, title={Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia.}, author={Sen K and Misra A and Kumar A and Pandey RM}, journal={Diabetes Res Clin Pract}, volume={56}, number={1}, pages={1-11}}"}}, {"_id": "21079205", "pmid": 21079205, "title": "ACP Journal Club. Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes.", "journal": "Ann Intern Med", "authors": ["Bronson DL"], "date": "2010-11-16T00:00:00Z", "doi": "10.7326/0003-4819-153-10-201011160-02010", "meta_date_publication": "2010 Nov 16", "meta_volume": "153", "meta_issue": "10", "meta_pages": "JC5-10", "score": 50056.152, "text_hl": "Intensifying @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ control and adding @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ each reduced progression of @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Bronson DL. ACP Journal Club. Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes. Ann Intern Med. 2010 Nov 16;153(10):JC5-10. PMID: 21079205", "BibTeX": "@article{21079205, title={ACP Journal Club. Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes.}, author={Bronson DL}, journal={Ann Intern Med}, volume={153}, number={10}, pages={JC5-10}}"}}, {"_id": "21436845", "pmid": 21436845, "title": "Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.", "journal": "Eye (Lond)", "authors": ["Wright AD", "Dodson PM"], "date": "2011-07-01T00:00:00Z", "doi": "10.1038/eye.2011.62", "meta_date_publication": "2011 Jul", "meta_volume": "25", "meta_issue": "7", "meta_pages": "843-9", "score": 50043.848, "text_hl": "In ACCORD Eye, @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ (160 mg daily) with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ resulted in a 40% reduction in the odds of @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ progressing over 4 years, compared with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ alone. ", "citations": {"NLM": "Wright AD, Dodson PM. Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies. Eye (Lond). 2011 Jul;25(7):843-9. PMID: 21436845", "BibTeX": "@article{21436845, title={Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.}, author={Wright AD and Dodson PM}, journal={Eye (Lond)}, volume={25}, number={7}, pages={843-9}}"}}, {"_id": "24380091", "pmid": 24380091, "title": "Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?", "journal": "Rev Diabet Stud", "authors": ["Agouridis AP", "Rizos CV", "Elisaf MS", "Filippatos TD"], "date": "2013-07-01T00:00:00Z", "doi": "10.1900/RDS.2013.10.171", "meta_date_publication": "2013 Summer-Fall", "meta_volume": "10", "meta_issue": "2-3", "meta_pages": "171-90", "score": 50038.152, "text_hl": "Furthermore, in the ACCORD study the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@/@CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ combination significantly reduced the rate of progression of @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ compared with statin/placebo administration in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@. ", "citations": {"NLM": "Agouridis AP, Rizos CV, Elisaf MS, Filippatos TD. Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia? Rev Diabet Stud. 2013 Summer-Fall;10(2-3):171-90. PMID: 24380091", "BibTeX": "@article{24380091, title={Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?}, author={Agouridis AP and Rizos CV and Elisaf MS and Filippatos TD}, journal={Rev Diabet Stud}, volume={10}, number={2-3}, pages={171-90}}"}}, {"_id": "23251757", "pmid": 23251757, "title": "Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.", "journal": "Ther Adv Chronic Dis", "authors": ["Hermans MP", "Fruchart JC"], "date": "2011-09-01T00:00:00Z", "doi": "10.1177/2040622311413952", "meta_date_publication": "2011 Sep", "meta_volume": "2", "meta_issue": "5", "meta_pages": "307-23", "score": 50032.45, "text_hl": "Therapeutic lifestyle changes and combination @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@-lowering therapy with drugs targeting @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherogenic dyslipidaemia@@@ (such as @CHEMICAL_Fibric_Acids @CHEMICAL_MESH:D058607 @@@fibrates@@@ or innovative drugs targeting @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherogenic dyslipidaemia@@@ and/or @GENE_APOB @GENE_338 @@@apolipoprotein B(100)@@@ metabolism) on top of background statins, have a potential to reduce RvR in high-risk groups, as shown in the Action to Control @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@Cardiovascular Risk@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ (ACCORD) trial, in which combination therapy with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ plus @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ decreased macrovascular risk in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherogenic dyslipidaemia@@@, and @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ risk irrespective of baseline @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipids@@@.", "citations": {"NLM": "Hermans MP, Fruchart JC. Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians. Ther Adv Chronic Dis. 2011 Sep;2(5):307-23. PMID: 23251757", "BibTeX": "@article{23251757, title={Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.}, author={Hermans MP and Fruchart JC}, journal={Ther Adv Chronic Dis}, volume={2}, number={5}, pages={307-23}}"}}, {"_id": "23631255", "pmid": 23631255, "title": "[Noninvasive analysis of retinal microstructure and function: challenges and a promising future].", "journal": "Nippon Ganka Gakkai Zasshi", "authors": ["Yoshida A"], "date": "2013-03-01T00:00:00Z", "meta_date_publication": "2013 Mar", "meta_volume": "117", "meta_issue": "3", "meta_pages": "212-44; discussion 245", "score": 50021.227, "text_hl": "In clinical studies, we found that the RBF decreased in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ with no or mild @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ compared with healthy subjects. ", "citations": {"NLM": "Yoshida A. [Noninvasive analysis of retinal microstructure and function: challenges and a promising future]. Nippon Ganka Gakkai Zasshi. 2013 Mar;117(3):212-44; discussion 245. PMID: 23631255", "BibTeX": "@article{23631255, title={[Noninvasive analysis of retinal microstructure and function: challenges and a promising future].}, author={Yoshida A}, journal={Nippon Ganka Gakkai Zasshi}, volume={117}, number={3}, pages={212-44; discussion 245}}"}}]}